Newswise Feature Channel: Blood

Pausing Biological Clock Could Boost Lab-Produced Blood Stem Cells

Iowa State University — Mon, 09 Sep 2024 16:05:49 EST

An Iowa State University research team has discovered when and why inflammatory signaling affects the formation of blood stem cells in embryos, which will benefit efforts to develop lab-grown, patient-derived stem cell transfusions to treat blood disorders. The promising advancement in regenerative medicine could eliminate the need for bone marrow transplants.

New Study Seeks to Develop a New Treatment Strategy to Prevent/Delay Relapse of Myeloid Leukemia Associated with Down Syndrome

Wayne State University Division of Research — Mon, 09 Sep 2024 14:05:02 EST

A four-year, $1.2 million grant from the National Cancer Institute of the National Institutes of Health to Wayne State University may help researchers find new clues to the interplay between Down syndrome and myeloid leukemia.

Medical Students Explore a Future in Research Through the Summer Oncology Research Fellowship Program

Children's Hospital Los Angeles — Fri, 06 Sep 2024 12:05:01 EST

For many students, summer break represents an opportunity for relaxation and carefree vacations. But for the medical students taking part in the USC/CHLA Summer Oncology Research Fellowship (SORF) Program, summer means something more

Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma

Johns Hopkins Medicine — Fri, 06 Sep 2024 11:00:00 EST

Age-related changes in the fibroblasts, cells that create the skin's structure, contribute to the development of aggressive, treatment-resistant melanoma in males, according to research in mice by the Johns Hopkins Kimmel Cancer Center.

Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk

Mayo Clinic — Thu, 05 Sep 2024 17:05:55 EST

About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition -- called monoclonal B-cell lymphocytosis (MBL) -- do not experience any symptoms, a new study shows they may have an elevated risk for several health complications, including melanoma, a form of skin cancer.

Study Estimates Home Blood Pressure Devices Don't Fit Properly for More than 17 Million U.S. Adults

Johns Hopkins Bloomberg School of Public Health — Thu, 05 Sep 2024 09:05:17 EST

Over-the-counter blood pressure measuring devices offer a simple, affordable way for people to track hypertension at home, but the standard arm-size ranges for these devices won't appropriately fit millions of U.S. consumers, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.

Adding anti-clotting drugs to stroke care ineffective, clinical trial finds

Washington University in St. Louis — Wed, 04 Sep 2024 17:00:00 EST

Opeolu Adeoye, MD a professor of emergency medicine at Washington University School of Medicine in St. Louis, led a national clinical trial that found that two anti-coagulant medications are ineffective at improving post-treatment outcomes for stroke patients.

Experts on the front lines of blood cancer see hope for cures

Sylvester Comprehensive Cancer Center — Tue, 03 Sep 2024 13:05:58 EST

Expert sources and news tips from Sylvester Comprehensive Cancer Center for Blood Cancer Awareness Month in September.

Understanding CAR-T cell therapy for cancer: Mayo Clinic expert explains how it works

Mayo Clinic — Tue, 03 Sep 2024 11:05:49 EST

For many doctors and researchers, immunotherapy that uses someone's own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, is one type of immunotherapy. Sometimes likened to a "smart drug" or "living drug," CAR-T cell therapy relies on genetically modified immune cells to recognize and destroy cancer cells.

Study evaluates factors associated with delayed time to treatment in multiple myeloma

Cleveland Clinic — Thu, 29 Aug 2024 16:05:27 EST

New anti-cancer 'degrader' targets protein essential to infant leukemia

Van Andel Institute — Thu, 29 Aug 2024 15:05:23 EST

Scientists have developed a potent anti-cancer compound that inhibits cancer cell growth in a tough-to-treat type of infant leukemia.

Presion arterial alta dana los rinones

Mayo Clinic — Wed, 28 Aug 2024 07:00:07 EST

La hipertension, tambien conocida como presion arterial alta, es un problema comun que afecta las arterias del cuerpo. Si tiene presion arterial alta, el corazon tiene que trabajar mas para bombear la sangre.

Pressao alta prejudica os rins

Mayo Clinic — Wed, 28 Aug 2024 07:00:05 EST

A hipertensao, tambem conhecida como pressao alta, e um problema comum que afeta as arterias do corpo. Se voce tem pressao alta, o coracao tem que trabalhar mais para bombear o sangue.

FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes

Florida State University — Thu, 22 Aug 2024 11:05:50 EST

New research led by Ayyalusamy Ramamoorthy, a professor at the FAMU-FSU College of Engineering and the Florida State University-headquartered National High Magnetic Field Laboratory, shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to Type 2 diabetes.

Type 2 diabetes increased by almost 20% over a decade

University of Georgia — Tue, 20 Aug 2024 08:05:21 EST

Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia.

Medical Oncologists Dr. Anokhi Patel and Dr. Peter Ledakis Guests on Mercy Medical Center's "MEDOSCOPY" series

Mercy Medical Center — Mon, 19 Aug 2024 17:05:21 EST

Medical oncologists Peter Ledakis, M.D. and Anokhi Patel, M.D. of Medical Oncology and Hematology at Mercy are guests of the hospital's ongoing talk show series, "Medoscopy," airing on Facebook Watch, Wed.-Thurs., Aug. 21st-22nd at 5:30 p.m. EST (www.facebook.com/MercyMedicalCenter).

American Society of Anesthesiologists Brings ANESTHESIOLOGY(r) 2024 to Philadelphia

American Society of Anesthesiologists (ASA) — Thu, 15 Aug 2024 11:05:41 EST

Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may be a simple way to reduce the risk of postoperative delirium. Combining two common blood tests may help doctors identify pregnant women who are at higher risk for life-threatening preeclampsia.

Could targeting metabolism treat blood clots in antiphospholipid syndrome?

Michigan Medicine - University of Michigan — Tue, 13 Aug 2024 09:05:03 EST

Neutrophils are an important type of white blood cell that help your immune system fight infections. One of the many ways neutrophils help is by capturing germs in sticky, spider web-like structures called neutrophil extracellular traps, or NETs.However, excessive formation of NETs is seen in many autoimmune diseases as a sign of exuberant inflammation.

Children's Hospital Los Angeles Names James F. Amatruda, MD, PhD, As Director Of The Cancer And Bloood Dicease Institute

Children's Hospital Los Angeles — Tue, 13 Aug 2024 06:05:28 EST

Children's Hospital Los Angeles has named James F. Amatruda, MD, PhD, a highly respected medical leader, clinician, and researcher with global recognitions, as Director of the Cancer and Blood Disease Institute and Alfred E. Mann Family Foundation Chair in Cancer Research at Children's Hospital Los Angeles

Scientists identify genes linked to relapse in the most common form of childhood leukemia

St. Jude Children's Research Hospital — Mon, 12 Aug 2024 11:50:31 EST

Scientists from St. Jude Children's Research Hospital, Seattle Children's and the Children's Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood cancer.